Skip to content
Nonprofiteer
← VERSITI INDIANA INC

Form 990 for tax year 2023

Filed by VERSITI INDIANA INC.

Totals

Total revenue
$87,010,628
Total expenses
$88,681,219
Contributions and grants received
$15,903
Grants paid
$45,483
Program service revenue
$85,136,503
Investment income
$1,661,373
Other revenue
$196,849
Total assets, end of year
$45,922,381
Total liabilities, end of year
$11,247,916
Net assets or fund balances, end of year
$34,674,465
Program services expenses (Part IX)
$76,937,977
Management and general expenses
$11,743,242
Fundraising expenses
$0
Program service expenses (Part III)
$76,937,977

Program services were 86.8% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1a · Federated campaigns

    $1,306

  • 1e · Government grants (contributions)

    $9,600

  • 1f · All other contributions, gifts and grants

    $4,997

  • 2a · Program service revenue: BLOOD SERVICES

    total $55,010,237 · related or exempt $55,010,237

  • 2b · Program service revenue: DONOR TESTING LABORATORY

    total $25,279,050 · related or exempt $25,279,050

  • 2c · Program service revenue: DIAGNOSTIC LABORATORIES

    total $4,482,735 · related or exempt $4,482,735

  • 2d · Program service revenue: MEDICAL SERVICES

    total $364,481 · related or exempt $364,481

  • 3 · Investment income

    total $598,492 · excluded $598,492

  • 7a · Gross sales of assets other than inventory

    securities $13,522,113 · other assets $76,247

  • 7b · Less cost or other basis and sales expenses

    securities $12,517,130 · other assets $18,349

  • 7c · Gain or loss

    securities $1,004,983 · other assets $57,898

  • 7d · Net gain or loss

    total $1,062,881 · excluded $1,062,881

  • 11a · Other revenue: AFFILIATE SERVICE FEES

    total $196,849 · excluded $196,849

  • 11e · Other revenue, total

    $196,849

Functional expenses

Part IX, the statement of functional expenses.

  • 1 · Grants to domestic organizations and governments

    total $35,483 · program services $35,483

  • 2 · Grants to domestic individuals

    total $10,000 · program services $10,000

  • 5 · Compensation of officers, directors and key employees

    total $1,480,260 · program services $369,050 · management and general $1,111,210

  • 7 · Other salaries and wages

    total $24,664,409 · program services $22,340,455 · management and general $2,323,954

  • 8 · Pension plan contributions

    total $1,358,296 · program services $1,210,506 · management and general $147,790

  • 9 · Other employee benefits

    total $4,078,224 · program services $3,586,827 · management and general $491,397

  • 10 · Payroll taxes

    total $1,848,290 · program services $1,610,045 · management and general $238,245

  • 11b · Fees: legal

    total $20,245 · program services $3,700 · management and general $16,545

  • 11f · Fees: investment management

    total $3,298 · management and general $3,298

  • 11g · Fees: other

    total $1,941,406 · program services $1,786,679 · management and general $154,727

  • 12 · Advertising and promotion

    total $701,112 · program services $77,596 · management and general $623,516

  • 13 · Office expenses

    total $366,315 · program services $325,373 · management and general $40,942

  • 14 · Information technology

    total $716,349 · program services $601,124 · management and general $115,225

  • 16 · Occupancy

    total $2,356,112 · program services $1,220,210 · management and general $1,135,902

  • 17 · Travel

    total $1,461,224 · program services $1,302,175 · management and general $159,049

  • 19 · Conferences, conventions and meetings

    total $59,965 · program services $31,526 · management and general $28,439

  • 20 · Interest

    total $28,787 · program services $22,161 · management and general $6,626

  • 22 · Depreciation, depletion and amortization

    total $1,821,543 · program services $1,203,307 · management and general $618,236

  • 23 · Insurance

    total $2,324 · management and general $2,324

  • 24a · Other expenses: MEDICAL LAB SUPPLIES

    total $27,418,972 · program services $27,417,913 · management and general $1,059

  • 24b · Other expenses: COST OF IMPORTED PROD

    total $10,335,077 · program services $10,335,077

  • 24c · Other expenses: VERSITI SERVICES ALLOC

    total $6,042,836 · program services $1,819,343 · management and general $4,223,493

  • 24d · Other expenses: EQUIPMENT LEASE & MAINT

    total $1,243,597 · program services $1,095,182 · management and general $148,415

  • 24e · All other expenses

    total $687,095 · program services $534,245 · management and general $152,850

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $0 · end of year $0

  • 2 · Savings and temporary cash investments

    beginning of year $0 · end of year $0

  • 3 · Pledges and grants receivable

    beginning of year $0 · end of year $0

  • 4 · Accounts receivable

    beginning of year $10,263,073 · end of year $17,130,849

  • 5 · Loans and receivables from officers and key people

    beginning of year $0 · end of year $0

  • 6 · Loans and receivables from disqualified persons

    beginning of year $0 · end of year $0

  • 7 · Other notes and loans receivable

    beginning of year $450,834 · end of year $0

  • 8 · Inventories for sale or use

    beginning of year $2,714,705 · end of year $2,938,991

  • 9 · Prepaid expenses and deferred charges

    beginning of year $371,310 · end of year $197,940

  • 10a · Land, buildings and equipment: cost or other basis

    $43,536,065

  • 10b · Land, buildings and equipment: accumulated depreciation

    $29,619,332

  • 10c · Land, buildings and equipment, net

    beginning of year $10,468,248 · end of year $13,916,733

  • 11 · Investments: publicly traded securities

    beginning of year $19,390,628 · end of year $10,552,707

  • 12 · Investments: other securities

    beginning of year $0 · end of year $0

  • 13 · Investments: program-related

    beginning of year $0 · end of year $0

  • 14 · Intangible assets

    beginning of year $0 · end of year $0

  • 15 · Other assets

    beginning of year $1,185,428 · end of year $1,185,161

  • 17 · Accounts payable and accrued expenses

    beginning of year $7,525,067 · end of year $8,857,877

  • 18 · Grants payable

    beginning of year $0 · end of year $0

  • 19 · Deferred revenue

    beginning of year $0 · end of year $0

  • 20 · Tax-exempt bond liabilities

    beginning of year $0 · end of year $0

  • 21 · Escrow or custodial account liability

    beginning of year $0 · end of year $0

  • 22 · Loans and payables to officers and key people

    beginning of year $0 · end of year $0

  • 23 · Secured mortgages and notes payable

    beginning of year $0 · end of year $0

  • 24 · Unsecured notes and loans payable

    end of year $0

  • 25 · Other liabilities

    beginning of year $1,031,064 · end of year $2,390,039

  • 27 · Net assets without donor restrictions

    beginning of year $36,020,284 · end of year $34,406,654

  • 28 · Net assets with donor restrictions

    beginning of year $267,811 · end of year $267,811

Mission and programs · 2023

Mission

(SEE SCHEDULE O)

  • VERSITI INDIANA, INC. (VERSITI) RECRUITS VOLUNTEER BLOOD DONORS, COLLECTS, PROCESSES AND DISTRIBUTES BLOOD AND BLOOD COMPONENTS TO PROVIDE A SAFE AND RELIABLE SUPPLY OF BLOOD FOR HOSPITALS AND OTHER BLOOD CENTERS SERVED. DURING 2023, 139,312 BLOOD UNITS WERE COLLECTED.VERSITI PROVIDES CLINICAL DIAGNOSTIC TESTING SERVICES TO HOSPITALS, PHYSICIAN OFFICES AND OTHER REFERENCE LABORATORIES. DURING 2023, 33,636 TESTS WERE PERFORMED.VERSITI MEDICAL SERVICES PROVIDES MEDICAL AND THERAPEUTIC SERVICES IN PARTNERSHIP WITH LOCAL HOSPITALS. DURING 2023, 63 THERAPEUTIC PROCEDURES WERE PERFORMED.

    Expenses $55,046,847 · Grants $45,483 · Revenue $59,857,453

  • VERSITI DONOR TESTING LABORATORY PROVIDES INFECTIOUS DISEASE TESTING TO DETERMINE DONOR SUITABILITY AND PRODUCT SAFETY FOR VERSITI AFFILIATES AND OTHER BLOOD CENTER PARTNERS. DURING 2023, 8,367,384 TESTS WERE PERFORMED.

    Expenses $21,891,130 · Revenue $25,279,050

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Chris Miskel

    PRESIDENT & CEO

    Total calculated
    $1,480,476
    From this org
    $285,020
    From related orgs
    $1,140,081
    Other
    $55,375
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $153,499 + $613,998 related
    Bonus
    $126,787 + $507,147 related
    Other
    $4,734 + $18,936 related
    Deferred
    $4,500 + $18,000 related
    Nontaxable benefits
    $6,575 + $26,300 related
    Filer's total
    $296,095 + $1,184,381 related
  • Fred Geilfuss

    CHAIR; LEGAL ADVISOR

    Total calculated
    $0
    Hours/week
    1 + 5 related
  • L Alan Whaley

    VICE CHAIR

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Sherry Husa

    SECRETARY

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Ron Miller

    TREASURER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Nicholas Bauer

    BOARD MEMBER - AS OF 3/23

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Coreen Dicus-Johnson JD

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • David Ginsburg MD

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Cecelia Gore

    BOARD MEMBER - AS OF 11/23

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Gail Hanson

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Thomas Hauske Jr

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 5 related
  • Dale Kent

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Robert H Manegold

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 5 related
  • Jeffrey S McDonald

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Maggey Oplinger

    BOARD MEMBER - AS OF 11/23

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • John Perras

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Kathy Thornton-Bias

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Greg Wesley

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Peter Ziegler

    BOARD MEMBER

    Total calculated
    $0
    Hours/week
    1 + 4 related
  • Bart Reuter

    EVP & GENERAL COUNSEL

    Total calculated
    $785,165
    From this org
    $144,188
    From related orgs
    $576,752
    Other
    $64,225
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $82,187 + $328,748 related
    Bonus
    $56,972 + $227,889 related
    Other
    $5,029 + $20,115 related
    Deferred
    $4,620 + $18,480 related
    Nontaxable benefits
    $8,225 + $32,900 related
    Filer's total
    $157,033 + $628,132 related
  • Anthony Watkins

    EVP & CHIEF FINANCIAL OFFICER

    Total calculated
    $781,954
    From this org
    $148,364
    From related orgs
    $593,459
    Other
    $40,131
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $85,942 + $343,771 related
    Bonus
    $56,442 + $225,769 related
    Other
    $5,980 + $23,919 related
    Deferred
    $4,620 + $18,480 related
    Nontaxable benefits
    $3,406 + $13,625 related
    Filer's total
    $156,390 + $625,564 related
  • Brian Bautista

    EVP & CHIEF OPERATING OFFICER

    Total calculated
    $741,795
    From this org
    $137,498
    From related orgs
    $549,995
    Other
    $54,302
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $90,738 + $362,954 related
    Bonus
    $42,456 + $169,825 related
    Other
    $4,304 + $17,216 related
    Deferred
    $3,963 + $15,853 related
    Nontaxable benefits
    $6,897 + $27,589 related
    Filer's total
    $148,358 + $593,437 related
  • Michael Deininger MD

    EVP & CHIEF SCIENTIFIC OFFICER

    Total calculated
    $683,113
    From this org
    $0
    From related orgs
    $643,660
    Other
    $39,453
    Hours/week
    1 + 54 related

    Schedule J breakdown matched by us

    Base
    $0 + $506,108 related
    Bonus
    $0 + $109,160 related
    Other
    $0 + $28,392 related
    Deferred
    $0 + $16,625 related
    Nontaxable benefits
    $0 + $22,828 related
    Filer's total
    $0 + $683,113 related
  • Gitesh Dubal

    EVP & CHIEF MARKETING OFFICER

    Total calculated
    $677,152
    From this org
    $124,033
    From related orgs
    $496,134
    Other
    $56,985
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $74,146 + $296,585 related
    Bonus
    $45,153 + $180,613 related
    Other
    $4,734 + $18,936 related
    Deferred
    $4,500 + $18,000 related
    Nontaxable benefits
    $6,897 + $27,588 related
    Filer's total
    $135,430 + $541,722 related
  • Bradley Pietz

    EVP & CHIEF LABORATORY OFFICER

    Total calculated
    $616,384
    From this org
    $110,682
    From related orgs
    $442,723
    Other
    $62,979
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $58,170 + $232,679 related
    Bonus
    $47,478 + $189,911 related
    Other
    $5,034 + $20,133 related
    Deferred
    $4,545 + $18,180 related
    Nontaxable benefits
    $8,051 + $32,203 related
    Filer's total
    $123,278 + $493,106 related
  • Barbara Bryant

    EVP & CHIEF MEDICAL OFFICER

    Total calculated
    $571,871
    From this org
    $0
    From related orgs
    $546,023
    Other
    $25,848
    Hours/week
    1 + 54 related

    Schedule J breakdown matched by us

    Base
    $0 + $509,725 related
    Bonus
    $0 + $18,210 related
    Other
    $0 + $18,088 related
    Deferred
    $0 + $23,100 related
    Nontaxable benefits
    $0 + $2,748 related
    Filer's total
    $0 + $571,871 related
  • James Weidner

    EVP & CHIEF HR OFFICER

    Total calculated
    $564,260
    From this org
    $101,922
    From related orgs
    $407,685
    Other
    $54,653
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $61,954 + $247,816 related
    Bonus
    $34,889 + $139,555 related
    Other
    $5,079 + $20,314 related
    Deferred
    $4,620 + $18,480 related
    Nontaxable benefits
    $6,311 + $25,242 related
    Filer's total
    $112,853 + $451,407 related
  • Alexandra Pieper

    VP & CHIEF QLT OFF - THRU 10/23

    Total calculated
    $563,684
    From this org
    $104,257
    From related orgs
    $417,023
    Other
    $42,404
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $42,759 + $171,033 related
    Bonus
    $15,750 + $63,000 related
    Other
    $45,748 + $182,990 related
    Deferred
    $3,231 + $12,924 related
    Nontaxable benefits
    $5,250 + $20,999 related
    Filer's total
    $112,738 + $450,946 related
  • Lynne Briggs

    VP & CHIEF INFORMATION OFFICER

    Total calculated
    $525,083
    From this org
    $94,821
    From related orgs
    $379,278
    Other
    $50,984
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $62,858 + $251,429 related
    Bonus
    $30,601 + $122,404 related
    Other
    $1,362 + $5,445 related
    Deferred
    $5,150 + $20,601 related
    Nontaxable benefits
    $5,046 + $20,187 related
    Filer's total
    $105,017 + $420,066 related
  • Dan Waxman MD

    VP TRANSFUSION MEDICINE

    Total calculated
    $487,067
    From this org
    $88,068
    From related orgs
    $352,272
    Other
    $46,727
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $72,864 + $291,454 related
    Bonus
    $11,380 + $45,520 related
    Other
    $3,824 + $15,298 related
    Deferred
    $4,620 + $18,480 related
    Nontaxable benefits
    $4,726 + $18,901 related
    Filer's total
    $97,414 + $389,653 related
  • Jessica Drouillard

    VP & CHIEF QLT OFF - AS OF 10/23

    Total calculated
    $178,272
    From this org
    $33,057
    From related orgs
    $132,227
    Other
    $12,988
    Hours/week
    11 + 44 related

    Schedule J breakdown matched by us

    Base
    $29,999 + $119,996 related
    Bonus
    $2,880 + $11,520 related
    Other
    $178 + $711 related
    Deferred
    $2,035 + $8,141 related
    Nontaxable benefits
    $562 + $2,250 related
    Filer's total
    $35,654 + $142,618 related
  • Julie Cruz MD

    SR MEDICAL DIRECTOR

    Total calculated
    $409,910
    From this org
    $373,764
    From related orgs
    $0
    Other
    $36,146
    Hours/week
    55

    Schedule J breakdown matched by us

    Base
    $343,396
    Bonus
    $26,700
    Other
    $3,668
    Deferred
    $21,159
    Nontaxable benefits
    $14,987
    Filer's total
    $409,910
  • Lora Poore

    SR STRATEGIST INNOVATION

    Total calculated
    $316,027
    From this org
    $269,844
    From related orgs
    $0
    Other
    $46,183
    Hours/week
    55

    Schedule J breakdown matched by us

    Base
    $225,847
    Bonus
    $40,300
    Other
    $3,697
    Deferred
    $16,560
    Nontaxable benefits
    $29,623
    Filer's total
    $316,027
  • Penny Schroeder

    AVP & SR DR DONOR TESTING LABS

    Total calculated
    $234,843
    From this org
    $219,959
    From related orgs
    $0
    Other
    $14,884
    Hours/week
    55

    Schedule J breakdown matched by us

    Base
    $188,521
    Bonus
    $23,900
    Other
    $7,538
    Deferred
    $13,575
    Nontaxable benefits
    $1,309
    Filer's total
    $234,843
  • Danielle Falconer

    AVP & DIRECTOR DONOR SERVICES

    Total calculated
    $151,506
    From this org
    $132,748
    From related orgs
    $0
    Other
    $18,758
    Hours/week
    55

    Schedule J breakdown matched by us

    Base
    $117,248
    Bonus
    $15,000
    Other
    $500
    Deferred
    $8,360
    Nontaxable benefits
    $10,398
    Filer's total
    $151,506
  • Nicholas Burrus

    DR MARKET INSIGHTS & OPERATIONS

    Total calculated
    $149,553
    From this org
    $138,713
    From related orgs
    $0
    Other
    $10,840
    Hours/week
    55

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Answered yes

  • 3 · Compensation committee
  • 3 · Independent compensation consultant
  • 3 · Form 990 of other organizations
  • 3 · Compensation survey or study
  • 3 · Approval by the board or compensation committee
  • 4a · Severance or change-of-control payment
  • 5a · Pay contingent on this organization's revenues
  • 5b · Pay contingent on a related organization's revenues
  • 6a · Pay contingent on this organization's net earnings
  • 6b · Pay contingent on a related organization's net earnings
  • 7 · Other non-fixed payments

Answered no

  • 4b · Supplemental nonqualified retirement plan
  • 4c · Equity-based compensation arrangement
  • 8 · Paid under the initial-contract exception

The filer's explanations (Part III)

PART I, LINE 3
TOP MANAGEMENT'S COMPENSATION THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, ACTING IN ITS CAPACITY AS THE COMPENSATION COMMITTEE, SETS AND MONITORS THE COMPENSATION PHILOSOPHY FOR THE FILING ORGANIZATION. OTHER THAN THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE EXECUTIVE COMMITTEE DOES NOT INCLUDE MEMBERS OF MANAGEMENT. TO ENSURE THAT THE COMMITTEE IS COMPRISED OF INDIVIDUALS WHO DO NOT HAVE A CONFLICT OF INTEREST WITH RESPECT TO VERSITI COMPENSATION ARRANGEMENTS, THE VERSITI PRESIDENT AND CHIEF EXECUTIVE OFFICER RECUSES HER/HIMSELF FROM ALL DISCUSSIONS AND APPROVALS RELATED TO HER/HIS COMPENSATION. THE EXECUTIVE COMMITTEE REVIEWS EXECUTIVE COMPENSATION ARRANGEMENTS TO ENSURE SUCH ARRANGEMENTS ARE FAIR, REASONABLE, AND NOT EXCESSIVE WHEN COMPARED TO SIMILARLY-SITUATED EXECUTIVES. EXECUTIVE COMPENSATION ARRANGEMENTS ARE REVIEWED FOR REASONABLENESS AND APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY IN ACCORDANCE WITH THE VERSITI REASONABLENESS REVIEW POLICY. IN ORDER TO ASSESS THE REASONABLENESS OF EXECUTIVE COMPENSATION ARRANGEMENTS, THE EXECUTIVE COMMITTEE OBTAINS AND REVIEWS APPROPRIATE COMPARABILITY DATA COLLECTED BY THE HUMAN RESOURCE DEPARTMENT AND/OR AN INDEPENDENT COMPENSATION CONSULTANT. THE EXECUTIVE COMMITTEE ENGAGES A QUALIFIED INDEPENDENT COMPENSATION CONSULTANT ANNUALLY. THE INDEPENDENT CONSULTANT PERFORMS AN ANALYSIS OF COMPENSATION LEVELS AT REGIONAL AND NATIONAL ORGANIZATIONS OF COMPARABLE SIZE, SCOPE AND STRUCTURE AND PROVIDES THE COMMITTEE WITH COMPREHENSIVE DATA ON THE AVAILABILITY OF SIMILAR SERVICES WITHIN THE GEOGRAPHIC AREA, COMPENSATION SURVEYS, WRITTEN OFFERS FROM SIMILAR INSTITUTIONS, AND OTHER INFORMATION RELEVANT TO COMPARABILITY OF COMPENSATION. THE EXECUTIVE COMMITTEE'S REVIEW, RECOMMENDATIONS AND APPROVALS ARE DOCUMENTED CONCURRENTLY IN THE COMMITTEE MINUTES, WHICH ARE SUBSEQUENTLY REVIEWED AND APPROVED BY THE EXECUTIVE COMMITTEE AS REASONABLE, ACCURATE AND COMPLETE. THE COMMITTEE CHAIR VERBALLY COMMUNICATES TO THE VERSITI BOARD OF DIRECTORS A CONFIRMATION OF COMPENSATION REASONABLENESS AND THE OVERALL DUE DILIGENCE PROCESS. VERSITI INDIANA HAS INCENTIVE PROGRAMS FOR THE CHIEF EXECUTIVE OFFICER AND OTHER CORPORATE OFFICERS DESCRIBED IN DETAILED WRITTEN POLICIES APPROVED BY THE EXECUTIVE COMMITTEE ANNUALLY. EVALUATION AND COMPENSATION REVIEW -CEO - EACH YEAR, THE EXECUTIVE COMMITTEE EVALUATES THE CEO'S PERFORMANCE AGAINST ESTABLISHED OBJECTIVES, DETERMINES INCENTIVE PAYMENT AND MERIT INCREASE BASED UPON PERFORMANCE AND MARKET DATA PROVIDED BY THE THIRD PARTY COMPENSATION CONSULTANT, AND WORKS WITH THE CEO TO ESTABLISH OBJECTIVES FOR THE NEXT YEAR. -OTHER CORPORATE OFFICERS - THE BOARD OF DIRECTORS HAS DELAGATED TO THE CEO THE PERFORMANCE ASSESSMENT AND COMPENSATION DECISIONS FOR HIS/HER TEAM AND LEADERS ELIGIBLE FOR THE VERSITI LEADERSHIP INCENTIVE PLAN. DURING THE MAY MEETING, THE EXECUTIVE COMMITTEE REVIEWS THE INCENTIVES (SHORT AND LONG-TERM) PAYOUTS AND MERIT INCREASES ASSIGNED TO THE EXECUTIVE TEAM AS PART OF THE ANNUAL COMPENSATION REASONABILITY REVIEW CONDUCTED BY AON CONSULTANTS. THE EXECUTIVE COMMITTEE REVIEWS AND APPROVES THE SALARY INCREASES AND INCENTIVE PAYOUTS OF THE CEO BEFORE PAYMENT. CORPORATE OFFICERS ARE POSITIONED WITHIN THE APPROPRIATE SALARY RANGE BASED UPON: -EXECUTIVE'S KNOWLEDGE, COMPETENCIES, AND EXPERIENCE, -PERFORMANCE OF THE EXECUTIVE'S AREAS OF RESPONSIBILITY, -THE EXECUTIVE'S CONTRIBUTION TO OVERALL PERFORMANCE, -THE IMPORTANCE OF RETAINING THE EXECUTIVE, -INTERNAL EQUITY CONSIDERATIONS, -THE FINANCIAL RESOURCES AVAILABLE, AND -EXECUTIVE BASE SALARY INCREASES PROVIDED IN THE COMPETITIVE MARKET
PART I, LINE 4A
SEVERANCE PAYMENT AN INDIVIDUAL RECEIVED A SEVERANCE PAYMENT. THE SEVERANCE IS INCLUDED IN COMPENSATION IN SCHEDULE J, PART II, COLUMN (B)(III).
PART I, LINES 5A, 5B, 6A, 6B AND 7:
NON-FIXED PAYMENTS INCENTIVE PAYOUT OPPORTUNITIES, BASED ON PERCENTAGE OF BASE PAY RATE, ARE AVAILABLE TO CERTAIN EMPLOYEES OF THE FILING ORGANIZATION. WHILE LEVELS OF THE INCENTIVE PAYOUT OPPORTUNITY ARE FIXED AND DETERMINED PERCENTAGES OF BASE COMPENSATION; THE INCENTIVE PAYOUT IS DETRMINED; IN PART, ON THE CONSOLIDATED REVENUE AND NET EARNINGS OF OPERATING DIVISIONS. THE INCENTIVE PAYOUT IS SUBJECT TO THE REVIEW OF ACCOMPLISHMENTS/OBJECTIVES AND THE ULTIMATE DETERMINATION OF INCENTIVE COMPENSATION IS SUBJECT TO PRESIDENT/CEO AND EXECUTIVE COMMITTEE OF THE BOARD APPROVAL.

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

Taxable family on this return

Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.

Related corporations and trusts

Part IV: related organizations taxable as a corporation or trust.

  • CENETRON DIAGNOSTICS LLC

    C · LABS & TRIALS · TX

Provenance

Return type
form_990
Tax year
2023
Filed
28 October 2024
IRS schema version
2023v5.1
Source object
202403039349301700

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.